Stratec Biomedical Systems

Stratec Biomedical Systems
ISIN DE000STRA555

STRATEC Biomedical AG is a company with worldwide operations that develops and produces analyzer systems and automation systems in the field of in-vitro-diagnostics. As a classic OEM (Original Equipment Manufacturer) supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also develops system software solutions and software to connect the systems to laboratory software (Middleware). Stratec is also responsible for development documentation, testing and delivering the systems, and supplying spare parts and consumables.[1]

Locations

Since its foundation, the company's headquarters has been in Birkenfeld in Enzkreis district, Gräfenhausen neighborhood. The company also has branches and development and production sites in Berlin, in Burton-upon-Trent, UK, in Newbury Park, USA, in Beringen, Switzerland, and in Cluj-Napoca, Romania.[2] History The company was founded in Birkenfeld in 1979. Stratec Biomedical AG was publicly listed (IPO) in 1998. The wholly owned subsidiary Robion AG was founded in Switzerland in 2005 and later renamed as Stratec Biomedical Switzerland AG. Sanguin International, Ltd., UK, was acquired in 2006 and renamed as Stratec Biomedical UK, Ltd. This was followed in 2009 by the acquisition of Invitek Gesellschaft für Biotechnik & Biodesign mbH, Berlin, now Stratec Molecular GmbH, and of Ballista, Inc., USA, now Stratec Biomedical USA, Inc. in 2010. In November 2010, the company was admitted into the TecDAX stock market index.

References

External links

This article is issued from Wikipedia - version of the Thursday, January 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.